Cited 3 time in
Development of novel IC-ELISA as a primary high throughput screening for various estrogen molecules
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Cha, M. | - |
| dc.contributor.author | Sohn, E.-T. | - |
| dc.contributor.author | Jung, E.-S. | - |
| dc.contributor.author | Kang, C. | - |
| dc.contributor.author | Lee, H. | - |
| dc.contributor.author | Jeong, S.-H. | - |
| dc.contributor.author | Kim, J.-S. | - |
| dc.contributor.author | Kim, E. | - |
| dc.date.accessioned | 2022-12-27T05:02:35Z | - |
| dc.date.available | 2022-12-27T05:02:35Z | - |
| dc.date.issued | 2010 | - |
| dc.identifier.issn | 2005-9752 | - |
| dc.identifier.uri | https://scholarworks.gnu.ac.kr/handle/sw.gnu/26027 | - |
| dc.description.abstract | An indirect competitive enzyme-linked immunosorbent assay (IC-ELISA) has been developed for detecting estrogen molecules in environmental samples. For generating anti-estrogen monoclonal antibody (mAb), BALB/c mice were immunized with 17-estra-diol (E2)-BSA and 5760 hybridoma cell lines were established. Through the optimization processes, a mAb(4BSA-e 3C11) and estriol(E3)-BSA were finally selected as a primary antibody and a coating antigen, respectively. The IC50 value for a standard estrogen (17β-E2) was 6.26 ng mL-1 and the detection range (20-80% B/B0) was 0.01-377.92ng mL-1. The developed IC-ELISA showed some cross-reactivities (CRs) to various estrogen analogues, such as estrone (E1) (1.79%), E3(77.34%), 16-epiestriol(27.54%) and 16 keto-17β-E2(2.02%). On the other hand, the assay showed a negligible CRs to other steroid hormones (CRs < 0.063%), suggesting the specificity of the assay to estrogen molecules. For assay validation, the developed IC-ELISA was compared side by side with high performance liquid chromatography (HPLC), which showed no significant difference in their performances between the two methods. The sensitivity of our IC-ELISA was approximately 100 fold higher than that of HPLC. The estrogen contents (Estrogen Equivalent Concentrations; EEC) in field samples were determined using the IC-ELISA, including swine sewage effluents (7.043 ± 0.023 ng-EEC mL-1), bovine feces (0.013±0.001 ng-EEC mL-1), and avian feces (0.017±0.001 ng-EEC mL-1). Conclusively, we have developed an IC-ELISA that is highly sensitive to estrogens as well as can detect various estrogen analogues at the same time. This assay can be used as a primary screening for a large number of field samples before the instrumental analysis that is laborintensive and time-consuming. ? 2010 The Korean Society of Environmental Risk Assessment and Health Science and Springer. | - |
| dc.format.extent | 10 | - |
| dc.language | 영어 | - |
| dc.language.iso | ENG | - |
| dc.title | Development of novel IC-ELISA as a primary high throughput screening for various estrogen molecules | - |
| dc.type | Article | - |
| dc.publisher.location | 대한민국 | - |
| dc.identifier.doi | 10.1007/BF03216513 | - |
| dc.identifier.scopusid | 2-s2.0-84872339687 | - |
| dc.identifier.bibliographicCitation | Toxicology and Environmental Health Sciences, v.2, no.1, pp 50 - 59 | - |
| dc.citation.title | Toxicology and Environmental Health Sciences | - |
| dc.citation.volume | 2 | - |
| dc.citation.number | 1 | - |
| dc.citation.startPage | 50 | - |
| dc.citation.endPage | 59 | - |
| dc.type.docType | Article | - |
| dc.description.isOpenAccess | N | - |
| dc.description.journalRegisteredClass | scopus | - |
| dc.subject.keywordAuthor | Enzyme-linked immunosorbent assay | - |
| dc.subject.keywordAuthor | Estrogens | - |
| dc.subject.keywordAuthor | High throughput screening | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
Gyeongsang National University Central Library, 501, Jinju-daero, Jinju-si, Gyeongsangnam-do, 52828, Republic of Korea+82-55-772-0532
COPYRIGHT 2022 GYEONGSANG NATIONAL UNIVERSITY LIBRARY. ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.
